{"id":"https://openalex.org/W2181906321","doi":null,"title":"Current state of type 2 diabetes management.","display_name":"Current state of type 2 diabetes management.","alternate_titles":[],"publication_year":2013,"publication_date":"2013-06-01","ids":{"openalex":"https://openalex.org/W2181906321","mag":"2181906321","pmid":"https://pubmed.ncbi.nlm.nih.gov/23844829"},"language":"en","primary_location":{"id":"pmid:23844829","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23844829","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2181906321"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060451560","display_name":"Mark E. Molitch","orcid":"https://orcid.org/0000-0002-8492-3587","observed_orcids":["https://orcid.org/0000-0002-8492-3587"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mark E Molitch","raw_affiliation_strings":["Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. molitch@northwestern.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. molitch@northwestern.edu","institution_ids":["https://openalex.org/I111979921"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5060451560"],"corresponding_institution_ids":["https://openalex.org/I111979921"],"apc_list":null,"apc_paid":null,"fwci":1.4321,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.80364297,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"19","issue":"8 Suppl","first_page":"S136","last_page":"S142"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9929999709129333},{"id":"https://openalex.org/keywords/diabetes-management","display_name":"diabetes management","score":0.9309999942779541},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.8119999766349792},{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.8270000219345093},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.6389999985694885},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7419999837875366},{"id":"https://openalex.org/keywords/management-guidelines","display_name":"management guidelines","score":0.5320000052452087},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4749999940395355}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9391058683395386},{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.6869105100631714},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.6584063172340393},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6542467474937439},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5297357439994812},{"id":"https://openalex.org/C2776217022","wikidata":"https://www.wikidata.org/wiki/Q1100933","display_name":"Diabetes management","level":4,"score":0.5144546031951904},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.49928784370422363},{"id":"https://openalex.org/C2778176773","wikidata":"https://www.wikidata.org/wiki/Q2976049","display_name":"Drug class","level":3,"score":0.49487990140914917},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.49166160821914673},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.47546881437301636},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.351715624332428},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32372117042541504},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3212008774280548},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.23853129148483276},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016601","descriptor_name":"RNA-Binding Proteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019538","descriptor_name":"Health Care Surveys","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019983","descriptor_name":"Guideline Adherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:23844829","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23844829","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Journal Article"},{"id":"mag:2181906321","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23844829","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W44929223","https://openalex.org/W57666350","https://openalex.org/W1523055845","https://openalex.org/W1566050174","https://openalex.org/W1894212043","https://openalex.org/W1980742633","https://openalex.org/W2016622896","https://openalex.org/W2017044017","https://openalex.org/W2036127635","https://openalex.org/W2036939737","https://openalex.org/W2054185381","https://openalex.org/W2057002261","https://openalex.org/W2068171948","https://openalex.org/W2085862152","https://openalex.org/W2093127997","https://openalex.org/W2095682936","https://openalex.org/W2096733280","https://openalex.org/W2111152015","https://openalex.org/W2111876001","https://openalex.org/W2143066955","https://openalex.org/W2147693969","https://openalex.org/W2149832640","https://openalex.org/W2164535707","https://openalex.org/W2171512247","https://openalex.org/W2510708214"],"related_works":["https://openalex.org/W1996561524","https://openalex.org/W2150219016","https://openalex.org/W1834805266","https://openalex.org/W2069935741","https://openalex.org/W2037500075","https://openalex.org/W2518837276","https://openalex.org/W2025454187","https://openalex.org/W2105476482","https://openalex.org/W2416781424","https://openalex.org/W1863279491"],"abstract_inverted_index":{"Type":[0],"2":[1,81],"diabetes":[2],"mellitus":[3],"(T2DM)":[4],"and":[5,29,45,95,113,142,149,174],"its":[6],"associated":[7],"comorbidities":[8],"are":[9,66],"a":[10,20,71],"major":[11],"public":[12],"health":[13],"issue":[14],"in":[15,53,67,83,88],"the":[16,37,77,84,110,119,128,169,180],"United":[17],"States.":[18],"Although":[19],"sizable":[21],"pharmacotherapeutic":[22],"armamentarium":[23],"exists":[24],"to":[25,56,91,127,144],"combat":[26],"this":[27],"disease":[28],"several":[30],"sources":[31],"have":[32],"published":[33],"evidence-based":[34],"management":[35,38,137],"guidelines,":[36,138],"of":[39,73,102,122,130,136,166,171,179],"patients":[40],"with":[41],"T2DM":[42,123],"remains":[43],"complex":[44,150],"suboptimal.":[46],"Currently":[47],"available":[48],"medications":[49,74],"target":[50],"various":[51,181],"organs":[52],"an":[54],"attempt":[55],"normalize":[57],"hyperglycemia;":[58],"however,":[59],"newer":[60],"agents":[61],"targeting":[62],"additional":[63],"organ":[64],"systems":[65],"development.":[68],"Among":[69],"these,":[70],"class":[72],"that":[75],"inhibit":[76],"sodium":[78],"glucose":[79,93,97],"cotransporter":[80],"(SGLT2)":[82],"kidney":[85],"show":[86],"promise":[87],"their":[89],"ability":[90],"decrease":[92],"reabsorption":[94],"increase":[96],"excretion.":[98],"In":[99],"particular,":[100],"one":[101],"these":[103],"compounds,":[104],"canagliflozin,":[105],"recently":[106],"was":[107],"approved":[108],"by":[109],"US":[111],"Food":[112],"Drug":[114],"Administration.":[115],"Despite":[116],"such":[117],"advances,":[118],"natural":[120],"course":[121],"often":[124],"eventually":[125],"leads":[126],"initiation":[129],"insulin":[131,151,167,176],"therapy.":[132],"A":[133],"working":[134],"knowledge":[135],"particularly":[139],"concerning":[140],"when":[141],"how":[143],"initiate":[145],"monotherapies,":[146],"combination":[147],"therapies,":[148],"regimens,":[152],"is":[153,186],"essential":[154],"for":[155,189],"optimal":[156],"patient":[157,191],"management.":[158,192],"Insulin":[159],"therapies":[160],"should":[161],"mimic":[162],"normal":[163],"physiologic":[164],"levels":[165],"through":[168],"use":[170],"both":[172],"basal":[173],"bolus":[175],"analogues.":[177],"Recognition":[178],"factors":[182],"influencing":[183],"therapeutic":[184],"choices":[185],"also":[187],"critical":[188],"improved":[190]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2181906321","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
